B:TACE

3 trials

Sponsors

Henan cancer hospital, The 105th Hospital of PLA, the 175th Hospital of PLA

Conditions

Diagnosed with primary hepatic carcinomaIntermediate hepatocellular carcinomathe Middle or Advaneed StageHepatoCellular Carcinoma(HCC)

Phase 2

A controlled trail on the efficacy and safety of TACE combined with umbilical cord blood cytokine-induced killer (CIK) cells infusion in hepatocellular carcinoma

Active, not recruitingChiCTR-ONRC-12002936

The 105th Hospital of PLADiagnosed with primary hepatic carcinoma

Start: 2013-02-06Updated: 2017-04-18

Phase 4

Multi-channel Blood Exclusion for the Treatment of the Middle or Advaneed Stage HepatoCellular Carcinoma (HCC)

RecruitingChiCTR-TRC-13003746

the 175th Hospital of PLAthe Middle or Advaneed StageHepatoCellular Carcinoma(HCC)

Start: 2013-10-01Updated: 2017-04-18

Unknown Phase

TACE plus sorafenib VS TACE monotherapy for the treatment of Multi-nodular hepatocellular carcinoma (Stage BCLC B): A prospective, multi-center comparison study

Active, not recruitingChiCTR-ONN-16007928

Henan cancer hospitalIntermediate hepatocellular carcinoma

Start: 2016-03-01Updated: 2017-04-18